GlassScriptPhysician profile
Jacob Olsen
NPI 1336841204
$2,118.31
in general payments reported to CMS, 2019-2025
7 companies · $662 in 2025
The $662 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $279 · 2024: $1,178 · 2025: $662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,066 · Education: $27.27 · Travel and Lodging: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,066.04 |
| Education | $27.27 |
| Travel and Lodging | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $500.00 | 2024-2025 | Auvelity |
| Abbvie INC. | $404.28 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $402.13 | 2024-2025 | Cobenfy |
| Neurocrine Biosciences, INC. | $300.59 | 2024-2025 | Ingrezza |
| Janssen Pharmaceuticals, INC | $274.64 | 2023-2024 | Invega Sustenna, Invega Trinza |
| Alkermes, INC. | $121.63 | 2025 | Aristada, Aristada Initio |
| Teva Pharmaceuticals USA, INC. | $115.04 | 2024 | Uzedy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Olsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.